UnitedHealthcare modified its clinical diagnostic laboratory services coverage policy, effective February 2, 2026. Here's what billing teams need to know.
UnitedHealthcare — full name UnitedHealthcare — updated this policy to clarify how it applies Medicare's medical necessity, screening versus diagnostic distinctions, and National Coverage Determination (NCD) requirements to clinical lab services. This policy does not list specific CPT or HCPCS codes. Instead, it governs the coverage framework your lab orders live inside — and getting that framework wrong is how you generate claim denials at scale.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | UnitedHealthcare |
| Policy | Clinical Diagnostic Laboratory Services |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | February 2, 2026 |
| Impact Level | High |
| Specialties Affected | Clinical laboratory, pathology, primary care, oncology, infectious disease, urology, OB/GYN, gastroenterology |
| Key Action | Audit your lab order documentation to confirm each test is linked to a correct screening or diagnostic indication before billing UnitedHealthcare claims |
UnitedHealthcare Clinical Laboratory Coverage Criteria and Medical Necessity Requirements 2026
The core of this coverage policy is the screening-versus-diagnostic distinction. UnitedHealthcare follows the Medicare framework exactly here. Get it wrong, and the reimbursement stops.
Screening tests are ordered when no sign, symptom, or diagnosis is present and the member has not been exposed to a disease. The purpose is early detection. Diagnostic tests are ordered because a sign or symptom exists. The sign or symptom must appear in the claim documentation to justify the test.
This distinction drives your ICD-10 selection. If you bill a screening test with a diagnostic ICD-10 — or vice versa — you're creating a medical necessity mismatch. That mismatch triggers a claim denial. It also creates audit exposure, because UnitedHealthcare's policy explicitly states that compliance is "subject to monitoring by post payment data analysis and subsequent medical review."
What "Reasonable and Necessary" Means Under This Policy
Under Section 1862(a)(1)(A) of the Social Security Act, Medicare — and by extension this UnitedHealthcare coverage policy — does not pay for services that are not reasonable and necessary. For clinical diagnostic laboratory services, that means every test must be:
| # | Covered Indication |
|---|---|
| 1 | Ordered by a treating physician or qualified nonphysician practitioner as described in 42 CFR 410.32(a) |
| 2 | Used promptly after ordering — not batched or delayed |
| 3 | Consistent with CLIA requirements under 42 CFR Part 493 |
The "used promptly" requirement is easy to overlook. If your workflow creates a lag between the order and the test, document why. An unexplained gap invites a post-payment review.
CLIA Compliance Is a Coverage Condition, Not Just a Regulatory Formality
This policy makes CLIA compliance a prerequisite for coverage — not a separate track. If your lab's CLIA certification has lapsed or if a test was performed outside the scope of your CLIA certificate, UnitedHealthcare has grounds to deny the claim entirely. Confirm your CLIA status is current and scoped correctly for every test type you're billing.
NCD and LCD Compliance Is Mandatory
UnitedHealthcare's clinical diagnostic laboratory services coverage policy requires compliance with all applicable CMS National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs). These aren't optional overlays — they're binding. If an NCD exists for a test your team is billing, that NCD's criteria govern coverage.
The policy references the following NCDs by name:
| # | Covered Indication |
|---|---|
| 1 | NCD 210.1 — Prostate Cancer Screening Tests |
| 2 | NCD 210.2 — Pap Tests Screening |
| 3 | NCD 210.2.1 — Cervical Cancer Screening with Human Papillomavirus (HPV) Tests |
| 4 | NCD 210.3 — Colorectal Cancer Screening Tests |
| 5 | NCD 210.6 — Screening for Hepatitis B Virus (HBV) Infection |
| 6 | NCD 210.7 — Human Immunodeficiency Virus (HIV) Screening |
| 7 | NCD 210.10 — Sexually Transmitted Infection (STI) & High Intensity Behavioral Counseling (HIBC) to Prevent STIs |
| 8 | NCD 210.13 — Screening for Hepatitis C Virus (HCV) in Adults |
For LCDs, UnitedHealthcare directs billers to the Medicare Coverage Database. Your Medicare Administrative Contractor (MAC) determines which LCDs apply in your region. Pull the relevant LCDs for your MAC jurisdiction and cross-check them against your high-volume lab codes. This is where regional billing guidelines diverge — and where billing teams get caught flat-footed.
UnitedHealthcare Clinical Laboratory Exclusions and Non-Covered Indications
The policy includes a "Nationally Non-Covered Indications" section. The full text was not available in the policy excerpt provided here. However, the structure matters: CMS nationally non-covered designations carry over directly into UnitedHealthcare's framework. If CMS has designated a test as nationally non-covered, UnitedHealthcare will not reimburse it regardless of what your ordering physician documents.
The clearest exclusion path in this policy is a failure to meet the screening-versus-diagnostic criteria. A test ordered without a valid indication — no sign, no symptom, no qualifying screening scenario — will not meet medical necessity and will not be covered. That's not ambiguous. It's the entire logical structure of this policy.
Prior authorization requirements are not explicitly detailed in this policy excerpt. If you're unsure whether prior authorization applies to specific high-cost or high-volume lab tests under your UnitedHealthcare contract, contact your UnitedHealthcare provider representative before the next billing cycle. Don't assume silence means no prior auth is required.
Coverage Indications at a Glance
| Indication | Status | Relevant NCD | Notes |
|---|---|---|---|
| Prostate Cancer Screening | Covered when criteria met | NCD 210.1 | Screening use only; no sign/symptom present |
| Pap Test Screening | Covered when criteria met | NCD 210.2 | Follow NCD frequency and eligibility criteria |
| Cervical Cancer Screening with HPV Tests | Covered when criteria met | NCD 210.2.1 | Specific coding criteria in Medicare Preventive Services Chart |
| Colorectal Cancer Screening | Covered when criteria met | NCD 210.3 | Screening use; eligibility based on age and risk |
| Hepatitis B Virus (HBV) Screening | Covered when criteria met | NCD 210.6 | Refer to Medicare Preventive Services Chart for coding |
| HIV Screening | Covered when criteria met | NCD 210.7 | Frequency limits apply |
| STI Screening & HIBC | Covered when criteria met | NCD 210.10 | High-intensity behavioral counseling component has separate coding |
| Hepatitis C Virus (HCV) Screening | Covered when criteria met | NCD 210.13 | Adults only; refer to Medicare Preventive Services Chart |
| Cardiovascular Disease Screening Tests | Covered when criteria met | Medicare Preventive Services Chart | No standalone NCD cited; use chart for coding criteria |
| Diabetes Screening | Covered when criteria met | Medicare Preventive Services Chart | Refer to chart for eligibility and frequency |
| Diagnostic lab tests (sign/symptom present) | Covered when medically necessary | 42 CFR 410.32(a) | Sign/symptom must appear in documentation |
| Tests ordered without valid indication | Not Covered | N/A | Fails medical necessity under Section 1862(a)(1)(A) |
| Nationally Non-Covered tests per CMS | Not Covered | Varies | CMS non-covered designations apply directly |
| Tests performed by non-CLIA-certified labs | Not Covered | 42 CFR Part 493 | CLIA compliance is a coverage prerequisite |
UnitedHealthcare Clinical Diagnostic Laboratory Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Audit your ICD-10 selection for all lab claims before February 2, 2026. Every lab claim needs to clearly support either a screening indication (no sign/symptom) or a diagnostic indication (sign/symptom present). Mismatched ICD-10 codes are your highest-risk exposure under this policy. |
| 2 | Pull the applicable NCDs for every preventive lab service your practice bills. NCDs 210.1 through 210.13 each have specific eligibility criteria, frequency limits, and coding requirements. Download the Medicare Preventive Services Chart and map your current charge capture against it. If your charge capture doesn't reflect current NCD criteria, update it now. |
| 3 | Contact your MAC to get current LCDs for your jurisdiction. UnitedHealthcare's coverage policy defers to LCDs for regional guidance. Your MAC's LCDs may impose additional coverage criteria beyond the NCDs. Clinical diagnostic laboratory billing in one region can look very different from another. Don't assume national NCD criteria are sufficient. |
| 4 | Verify your CLIA certification is current and covers every test type you're billing. Pull your CLIA certificate and cross-check the test categories against your claim volume. If you've added new test types without updating your CLIA scope, you have a coverage gap that UnitedHealthcare can — and will — use to deny claims post-payment. |
| 5 | Document the ordering provider's credentials and the prompt-use timeline. The policy requires that lab services be ordered by a treating physician or qualified nonphysician practitioner and used promptly. Flag any workflow that creates a delay between order and test. Build documentation of the order-to-result timeline into your lab records. |
| 6 | Flag high-cost diagnostic lab orders for prior authorization review. This policy doesn't enumerate prior auth requirements explicitly, but UnitedHealthcare contracts often include them for specific lab categories. If you're not sure how this applies to your test mix, talk to your compliance officer before the effective date. |
| 7 | Set up a post-payment audit review cadence. UnitedHealthcare explicitly states this policy is subject to "post payment data analysis and subsequent medical review." That's a direct signal. Build a quarterly internal audit of your clinical diagnostic laboratory billing against medical necessity documentation. Catch it before they do. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Clinical Diagnostic Laboratory Services Under This Policy
This UnitedHealthcare coverage policy does not list specific CPT, HCPCS, or ICD-10 codes. This is a framework policy. It governs how coverage decisions are made for the entire category of clinical lab services, not individual codes.
For code-level guidance, you need to go to the source documents this policy points to:
- NCDs 210.1 through 210.13 — available in the CMS National Coverage Determinations database
- Your MAC's LCDs — available in the Medicare Coverage Database at cms.gov
- The Medicare Preventive Services Chart — published by CMS and updated annually
Each NCD and LCD will list the specific CPT and HCPCS codes that apply to each covered indication. Pull those documents and map your charge master against them. That's the only way to confirm your clinical diagnostic laboratory billing is aligned with this policy in practice.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.